Skip to content

Comparison of the Effects of Vapocoolant Spray and EMLA Cream on Pain During Needle Electromyography

Comparison of the Effects of Vapocoolant Spray and Topical Anesthetic Cream on Pain During Needle Electromyography: a Randomized Controlled Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01606046
Enrollment
99
Registered
2012-05-25
Start date
2011-07-31
Completion date
2011-08-31
Last updated
2012-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrodiagnosis

Brief summary

The purpose of this study is to compare the effects of vapocoolant spray and topical lidocaine 2.5% + prilocaine 2.5% cream (EMLA) on reducing pain during needle electromyography.

Detailed description

The study was conducted on patients with patients that underwent needle EMGs in the lower extremity between July and August 2011 at the university hospital. The patients were divided into a total of three groups by random assignment: a control group that did not receive pretreatment, a group that received ethyl chloride vapocoolant spray and a group that received topical anesthetic cream (EMLA cream®).The patients with spray group, they were sprayed with ethyl chloride vapocoolant spray for 5 seconds from a distance of 30 cm just before the needle EMG, and patients with EMLA cream, they received an application of topical anesthetic cream on the needle electrode insertion site 60 minutes before the needle EMG. The 37-mm monopolar needle electrode was vertically inserted into the medial head of the gastrocnemius muscle in all patients. To assess the degree of pain for each group, patients were asked to indicate their level of pain on a 100 mm VAS (0, no pain; 100, worst intolerable pain) after the needle EMG in the gastrocnemius muscle. In both experimental groups, a 5-point Likert scale was used to evaluate patient satisfaction with the pain reduction method used and their willingness to use the same analgesic method in another EMG.

Interventions

spray for 5 seconds from a distance of 30 cm just before the needle EMG

application of EMLA cream on the needle electrode insertion site 60 minutes before the needle EMG

Sponsors

The Catholic University of Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who had a normal schedule of needle EMGs in the lower extremity.

Exclusion criteria

1. those who refused to participate in the experiment 2. those who were unable to understand a VAS and Likert scale 3. those with a history of allergic reaction to vapocoolant spray or lidocaine 4. those with a history of cold intolerance (Raynaud's syndrome, etc.) 5. those who took oral pain medications or used topical anesthetics within 24 hours of the experiment 6. those who exhibited abnormal lower extremity sensation during the physical examination or who showed pain on gastrocnemius

Design outcomes

Primary

MeasureTime frame
visual analogue scale, 5 point Likert scaleImmediately after the complete of needle electromyography

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026